A meta-analysis comparing regorafenib with TAS-102 for treating refractory metastatic colorectal cancer

OBJECTIVE: We performed this meta-analysis to compare the efficacy and toxicity of regorafenib and TAS-102. METHODS: Electronic databases were searched to identify studies comparing the efficacy and safety of regorafenib and TAS-102 in patients with chemotherapy-refractory metastatic colorectal canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Guan-Li, Wang, Yuan-Yuan, Wang, Jin-Cheng, Liu, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361493/
https://www.ncbi.nlm.nih.gov/pubmed/32660291
http://dx.doi.org/10.1177/0300060520926408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361493/
https://www.ncbi.nlm.nih.gov/pubmed/32660291
http://dx.doi.org/10.1177/0300060520926408

Ejemplares similares